Biotech | Crain's Dallas

Business news covering technology created by living systems.

Stopping the scourge: An all-out effort to fight opioid addiction

Buprenorphine is used in medication-assisted treatment to aid people addicted to narcotic pain relievers. | Photo courtesy of Pixabay

March 20, 2018 - 5:16pm

UTD researcher wants to attack pain at the source

Ted Price, an associate professor and neuroscience program head at the University of Texas at Dallas, is hard at work on alternative treatments for pain. | Photo courtesy of UTD.

March 13, 2018 - 10:50am

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Jeff Terry

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Daniel Levitt

Background:  

Texas nutrition company bets big on algae source of omega-3

Texas native and microbiologist Rebecca White joined Houston-based Qualitas Health in 2015 after working at Sapphire Energy in the algae-based biofuels field. | Photo courtesy of Qualitas Health

June 13, 2017 - 2:23pm

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Elyse Dickerson

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Ross Toohey

Background:  

Giving workers more flexibility can extend lives, study finds

Celadon Trucking’s Gordon Day is taking advantage of a new company policy that allows drivers to take their cats and dogs on the road with them. An Indiana University study found that giving workers in high-stress jobs additional freedom isn’t just a morale booster but could also help them live longer. | Photo courtesy of Celadon Trucking

October 27, 2016 - 3:58pm

San Antonio doc says cancer ‘moonshot’ must tap new biotech, pharma

Dr. Anthony Tolcher is director of clinical research at San Antonio-based South Texas Accelerated Research Therapeutics (START), a global leader in Phase I medical oncology.

June 2, 2016 - 2:56pm